Carved in stone? [Study As­sess­ment]

posted by sam – India, 2013-08-02 11:01 (4706 d 04:14 ago) – Posting: # 11164
Views: 30,634

Hi Luvblooms,

❝ I must say a very very BOLD decision to go ahead with the study!!


I don’t have other option as the management wanted to go with this study

❝ But since you have already taken some bold steps, you can try the redosing process and if lucky, submit the data with redosing study but you need to define it properly in the redosing protocol.


Suppose I am doing re-dosing study and it meets all the acceptance. I am worried will USFDA accept the dossier as they don’t encourage the same.

❝ And If I am right, you have to submit the full study results.

❝ I mean to say

❝ a. Original study data including outlier

❝ b. You cannot remove the outlier from study, If you are able to find your proposed outlier as real outlier in redosing study, the data of the outliers in the original study to be replaced with the data obtained in the redosing study and then BE to be calculated.


I don’t think the redosing study is performed to get the new data which can be used for substitution of the old data, as per my understanding it is only done to prove that the detected outlier is really outlier and the outlier will proved than you have the submit the data with and without outlier.

❝ BTW, was the study fasting or fed? And what was the outcome of other study (fasting/fed)?


Its fed study and we are waiting the fasting study results.

Best Regards

Sam

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
125 visitors (0 registered, 125 guests [including 24 identified bots]).
Forum time: 15:15 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5